Company registration number SC402097 (Scotland)
RENAISSANCE CARE (NO 1) LIMITED
ANNUAL REPORT AND FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 NOVEMBER 2025
RENAISSANCE CARE (NO 1) LIMITED
COMPANY INFORMATION
Directors
Mr R D Kilgour
Mrs A Neilson
Mrs L Barnett
Mr L M Bain
Company number
SC402097
Registered office
Archibald Hope House
Station Road
Musselburgh
Scotland
EH21 7PQ
Auditor
Thomson Cooper
3 Castle Court
Carnegie Campus
Dunfermline
Fife
KY11 8PB
Bankers
Barclays Bank (Canary Wharf)
1 Churchill Place
Canary Wharf
London
E14 5HP
Solicitors
Morton Fraser MacRoberts LLP
Level 5
9 Haymarket Square
Edinburgh
EH3 8RY
RENAISSANCE CARE (NO 1) LIMITED
CONTENTS
Page
Strategic report
1
Directors' report
2 - 3
Independent auditor's report
4 - 6
Statement of comprehensive income
7
Balance sheet
8
Statement of changes in equity
9
Statement of cash flows
10
Notes to the financial statements
11 - 21
RENAISSANCE CARE (NO 1) LIMITED
STRATEGIC REPORT
FOR THE YEAR ENDED 30 NOVEMBER 2025
- 1 -
The directors present the strategic report for the year ended 30 November 2025.
Business Review
Profit after taxation for the year was £1,571,335 (2024 - £1,642,441) and had reserves of £5,135,954 (2024 - £3,564,620) at the balance sheet date. The company has a strong cash balance of £2,052,048 (2024 - £1,622,834).
Key Performance Indicators
2025
2024
2023
Care Inspection Scores (Average)
4.2
4.0
4.0
£
£
£
Turnover
31,388,205
29,595,957
27,052,686
EBITDAR
6,212,607
6,013,692
5,170,327
Care Inspection Quality Ratings; the average Care Inspection score achieved across all homes. Homes are rated out of 6 (2 being Weak, 4 being Good and 6 being Excellent).
Average Occupancy; the percentage of registered beds occupied, on average, over the year.
Turnover; total sales achieved.
EBITDAR; earnings before Interest, Tax, Depreciation, Amortisation and Rent.
The Board are encouraged that the company has continued to trade profitably and expects it to do so during the next accounting period.
Principal Risks and Uncertainties
The company, similar to any business, faces a number of operating risks and uncertainties that could impact the company's performance. Steps are taken to understand and evaluate these risks and to mitigate against them in order to achieve the Directors' long term goal of creating a sustainable business which delivers benefits to all stakeholders. The most fundamental risks faced by the company are:
Failure to:
comply with regulation which, in extreme cases, could result in the removal of a care home's registration
meet quality standards resulting in an operating embargo on new admissions to one or more homes
reach a satisfactory fee settlement with commissioning local authorities
achieve budgeted occupancy levels
achieve budgeted average fee rates
attract, train and motivate suitably qualified staff
reduce use of agency labour
meet bank covenants
Rising costs also pose a significant risk. Both short term and long term forecasts have been modelled to confirm our stability and we are closely monitoring operations and the financial impact on our business.
Mr L M Bain
Director
27 May 2026
RENAISSANCE CARE (NO 1) LIMITED
DIRECTORS' REPORT
FOR THE YEAR ENDED 30 NOVEMBER 2025
- 2 -
The directors present their annual report and financial statements for the year ended 30 November 2025.
Principal activities
The principal activity of the company continued to be that of the operation of care homes for the elderly.
Results and dividends
The results for the year are set out on page 7.
No ordinary dividends were paid. The directors do not recommend payment of a final dividend.
Directors
The directors who held office during the year and up to the date of signature of the financial statements were as follows:
Mr R D Kilgour
Mrs A Neilson
Mrs L Barnett
Mr L M Bain
Supplier payment policy
The company's policy is to pay suppliers in a timely manner. The company clearly understands that the maintenance of a reliable payment pattern is important to suppliers and that suppliers' support is fundamental to the success of the business.
Disabled persons
Applications for employment by disabled persons are always fully considered, bearing in mind the aptitudes of the applicant concerned. In the event of members of staff becoming disabled, every effort is made to ensure that their employment within the company continues and that the appropriate training is arranged. It is the policy of the company that the training, career development and promotion of disabled persons should, as far as possible, be identical to that of other employees.
Employee involvement
The company looks to recruit, develop and employ throughout the organisation appropriately qualified, capable and experienced staff irrespective of race, religion or sexual orientation. Full consideration is given to applications from disabled persons - looking to their particular aptitudes and abilities. Equally, any employee becoming disabled during their employment will be assessed for their suitability for continued employment and offered retraining or redeployment as required.
The company communicates with its staff in staff meetings, by letter and through its regular staff newsletter. During the year, the company has increased its use of social media channels to communicate with staff to good effect.
All employees are encouraged in terms of their career development and the company generally supports those who undertake further qualifications. The company continues to train its senior care staff to undertake many of the tasks normally regarded as the responsibility of trained nurses. Subject to Care Inspectorate approval, deployment of these staff members helps controls costs and reduces reliance on nurses.
Auditor
In accordance with the company's articles, a resolution proposing that Thomson Cooper be reappointed as auditor of the company will be put at a General Meeting.
Statement of directors' responsibilities
The directors are responsible for preparing the annual report and the financial statements in accordance with applicable law and regulations.
RENAISSANCE CARE (NO 1) LIMITED
DIRECTORS' REPORT (CONTINUED)
FOR THE YEAR ENDED 30 NOVEMBER 2025
- 3 -
Statement of disclosure to auditor
So far as each person who was a director at the date of approving this report is aware, there is no relevant audit information of which the company’s auditor is unaware. Additionally, the directors individually have taken all the necessary steps that they ought to have taken as directors in order to make themselves aware of all relevant audit information and to establish that the company’s auditor is aware of that information.
On behalf of the board
Mr L M Bain
Director
27 May 2026
RENAISSANCE CARE (NO 1) LIMITED
INDEPENDENT AUDITOR'S REPORT
TO THE MEMBERS OF RENAISSANCE CARE (NO 1) LIMITED
- 4 -
Opinion
We have audited the financial statements of Renaissance Care (No 1) Limited (the 'company') for the year ended 30 November 2025 which comprise the statement of comprehensive income, the balance sheet, the statement of changes in equity, the statement of cash flows and notes to the financial statements, including significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland (United Kingdom Generally Accepted Accounting Practice).
In our opinion the financial statements:
give a true and fair view of the state of the company's affairs as at 30 November 2025 and of its profit for the year then ended;
have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and
have been prepared in accordance with the requirements of the Companies Act 2006.
We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditor's responsibilities for the audit of the financial statements section of our report. We are independent of the company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.
Conclusions relating to going concern
In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.
Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.
Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.
The other information comprises the information included in the annual report other than the financial statements and our auditor's report thereon. The directors are responsible for the other information contained within the annual report. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon. Our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the course of the audit, or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.
We have nothing to report in this regard.
Opinions on other matters prescribed by the Companies Act 2006
In our opinion, based on the work undertaken in the course of our audit:
the information given in the strategic report and the directors' report for the financial year for which the financial statements are prepared is consistent with the financial statements; and
the strategic report and the directors' report have been prepared in accordance with applicable legal requirements.
RENAISSANCE CARE (NO 1) LIMITED
INDEPENDENT AUDITOR'S REPORT
TO THE MEMBERS OF RENAISSANCE CARE (NO 1) LIMITED (CONTINUED)
- 5 -
Matters on which we are required to report by exception
In the light of the knowledge and understanding of the company and its environment obtained in the course of the audit, we have not identified material misstatements in the strategic report and the directors' report. We have nothing to report in respect of the following matters in relation to which the Companies Act 2006 requires us to report to you if, in our opinion:
adequate accounting records have not been kept, or returns adequate for our audit have not been received from branches not visited by us; or
the financial statements are not in agreement with the accounting records and returns; or
certain disclosures of directors' remuneration specified by law are not made; or
we have not received all the information and explanations we require for our audit; or
the directors were not entitled to prepare the financial statements in accordance with the small companies regime and take advantage of the small companies' exemption in preparing the directors' report.
Responsibilities of directors
As explained more fully in the directors' responsibilities statement, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error. In preparing the financial statements, the directors are responsible for assessing the company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the company or to cease operations, or have no realistic alternative but to do so.
Auditor's responsibilities for the audit of the financial statements
Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor's report that includes our opinion. Reasonable assurance is a high level of assurance but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.
The extent to which our procedures are capable of detecting irregularities, including fraud, is detailed below.
Extent to which the audit was considered capable of detecting irregularities, including fraud
We considered the opportunities and incentives that may exist within the organisation for fraud and identified the greatest potential for fraud in the following areas: existence and timing of recognition of income, posting of unusual journals, along with complex transactions. We evaluated the business purpose of significant unusual transactions, and considered the nature of the industry, the control environment and business performance. We discussed these risks with management, designed audit procedures to test the timing and existence of revenue, tested a sample of journals to confirm they were appropriate, used analytical procedures to identify any unusual or unexpected relationships, and reviewed areas of judgement for indicators of management bias to address these risks.
We identified areas of laws and regulations that could reasonably be expected to have a material effect on the financial statements from our sector experience through discussion with the officers and other management (as required by the auditing standards).
We reviewed the laws and regulations in areas that directly affect the financial statements including financial and taxation legislation and Care Inspectorate regulations recognising the regulated nature of the company’s activities. We considered the extent of compliance with those laws and regulations as part of our procedures on the related financial statement items.
With the exception of any known or possible non-compliance with relevant and significant laws and regulations, and as required by the auditing standards, our work in respect of these was limited to enquiry of the officers and management of the company.
We communicated identified laws and regulations throughout our team and remained alert to any indications of non-compliance throughout the audit.
RENAISSANCE CARE (NO 1) LIMITED
INDEPENDENT AUDITOR'S REPORT
TO THE MEMBERS OF RENAISSANCE CARE (NO 1) LIMITED (CONTINUED)
- 6 -
Owing to the inherent limitations of an audit, there is an unavoidable risk that we may not have detected some material misstatements in the financial statements, even though we have properly planned and performed our audit in accordance with auditing standards. We are not responsible for preventing non-compliance and cannot be expected to detect non-compliance with all laws and regulations.
These inherent limitations are particularly significant in the case of misstatement resulting from fraud as this may involve sophisticated schemes designed to avoid detection, including deliberate failure to record transactions, collusion or the provision of intentional misrepresentations.
A further description of our responsibilities is available on the Financial Reporting Council’s website at: https://www.frc.org.uk/auditorsresponsibilities. This description forms part of our auditor's report.
This report is made solely to the company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company's members those matters we are required to state to them in an auditor's report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company's members as a body, for our audit work, for this report, or for the opinions we have formed.
Sharon Collins (Senior Statutory Auditor)
For and on behalf of Thomson Cooper, Statutory Auditor
Dunfermline
28 May 2026
RENAISSANCE CARE (NO 1) LIMITED
STATEMENT OF COMPREHENSIVE INCOME
FOR THE YEAR ENDED 30 NOVEMBER 2025
- 7 -
2025
2024
Notes
£
£
Turnover
31,388,205
29,595,956
Cost of sales
(18,825,180)
(16,881,735)
Gross profit
12,563,025
12,714,221
Administrative expenses
(10,683,844)
(10,864,404)
Operating profit
1,879,181
1,849,817
Interest receivable and similar income
3,103
4,572
Interest payable and similar expenses
(661)
(743)
Profit before taxation
1,881,623
1,853,646
Tax on profit
5
(310,288)
(211,205)
Profit for the financial year
1,571,335
1,642,441
The profit and loss account has been prepared on the basis that all operations are continuing operations.
RENAISSANCE CARE (NO 1) LIMITED
BALANCE SHEET
AS AT
30 NOVEMBER 2025
30 November 2025
- 8 -
2025
2024
Notes
£
£
£
£
Fixed assets
Intangible assets
6
25,589
36,236
Tangible assets
7
2,437,047
2,345,134
2,462,636
2,381,370
Current assets
Debtors
8
12,999,010
11,069,730
Cash at bank and in hand
2,052,048
1,622,834
15,051,058
12,692,564
Creditors: amounts falling due within one year
9
(11,908,387)
(11,121,751)
Net current assets
3,142,671
1,570,813
Total assets less current liabilities
5,605,307
3,952,183
Creditors: amounts falling due after more than one year
10
(17,888)
Provisions for liabilities
12
(469,352)
(369,675)
Net assets
5,135,955
3,564,620
Capital and reserves
Called up share capital
1
1
Profit and loss reserves
5,135,954
3,564,619
Total equity
5,135,955
3,564,620
These financial statements have been prepared in accordance with the provisions relating to medium-sized companies.
The financial statements were approved by the board of directors and authorised for issue on 27 May 2026 and are signed on its behalf by:
Mr L M Bain
Director
Company registration number SC402097 (Scotland)
RENAISSANCE CARE (NO 1) LIMITED
STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 30 NOVEMBER 2025
- 9 -
Share capital
Profit and loss reserves
Total
£
£
£
Balance at 1 December 2023
1
1,922,178
1,922,179
Year ended 30 November 2024:
Profit and total comprehensive income
-
1,642,441
1,642,441
Balance at 30 November 2024
1
3,564,619
3,564,620
Year ended 30 November 2025:
Profit and total comprehensive income
-
1,571,335
1,571,335
Balance at 30 November 2025
1
5,135,954
5,135,955
RENAISSANCE CARE (NO 1) LIMITED
STATEMENT OF CASH FLOWS
FOR THE YEAR ENDED 30 NOVEMBER 2025
- 10 -
2025
2024
Notes
£
£
£
£
Cash flows from operating activities
Cash generated from operations
17
1,405,501
1,971,453
Interest paid
(661)
(743)
Income taxes paid
(209,329)
(209,233)
Net cash inflow from operating activities
1,195,511
1,761,477
Investing activities
Purchase of intangible assets
(1,686)
(36,236)
Proceeds from disposal of intangibles
8,340
Purchase of tangible fixed assets
(753,661)
(1,098,625)
Proceeds from disposal of tangible fixed assets
80,018
Interest received
3,103
4,572
Net cash used in investing activities
(743,904)
(1,050,271)
Financing activities
Payment of finance leases obligations
(22,393)
(4,505)
Net cash used in financing activities
(22,393)
(4,505)
Net increase in cash and cash equivalents
429,214
706,701
Cash and cash equivalents at beginning of year
1,622,834
916,133
Cash and cash equivalents at end of year
2,052,048
1,622,834
RENAISSANCE CARE (NO 1) LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 NOVEMBER 2025
- 11 -
1
Accounting policies
Company information
Renaissance Care (No 1) Limited is a private company limited by shares incorporated in Scotland. The registered office is Archibald Hope House, Station Road, Musselburgh, Scotland, EH21 7PQ.
1.1
Basis of preparation
These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.
The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.
The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.
This company is a qualifying entity for the purposes of FRS 102, being a member of a group where the parent of that group prepares publicly available consolidated financial statements, including this company, which are intended to give a true and fair view of the assets, liabilities, financial position and profit or loss of the group. The company has therefore taken advantage of exemptions from the following disclosure requirements:
Section 7 ‘Statement of Cash Flows’: Presentation of a statement of cash flow and related notes and disclosures;
Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instrument Issues’: Interest income/expense and net gains/losses for each category of financial instrument; basis of determining fair values; details of collateral, loan defaults or breaches, details of hedges, hedging fair value changes recognised in profit or loss and in other comprehensive income;
Section 33 ‘Related Party Disclosures’: Compensation for key management personnel.
The financial statements of the company are consolidated in the financial statements of Dow Investments PLC. These consolidated financial statements are available from its registered office, Archibald Hope House, Station Road, Musselburgh, Scotland, EH21 7PQ.
1.2
Going concern
At the time of approving the financial statements, the directors consider that the company has adequate resources to continue in operational existence for a period of not less than 12 months. The directors have reviewed their budgets and cashflow requirements and are satisfied that the group has sufficient cash reserves and net income trueand consider that this is sufficient to ensure short term liquidity and longer-term financial viability of the group. As such the directors continue to adopt the going concern basis of accounting in preparing the financial statements.
1.3
Revenue
Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes.
Revenue represents fee income relating to the provision of care services. Fee income comprises residential, nursing and personal care services which are recognised when the delivery of service is completed. Fees invoiced in advance are included as deferred income until the service is completed.
RENAISSANCE CARE (NO 1) LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 NOVEMBER 2025
1
Accounting policies
(Continued)
- 12 -
1.4
Intangible fixed assets other than goodwill
Intangible assets acquired separately from a business are recognised at cost and are subsequently measured at cost less accumulated amortisation and accumulated impairment losses.
Intangible assets acquired on business combinations are recognised separately from goodwill at the acquisition date where it is probable that the expected future economic benefits that are attributable to the asset will flow to the entity and the fair value of the asset can be measured reliably; the intangible asset arises from contractual or other legal rights; and the intangible asset is separable from the entity.
Amortisation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:
Patents & licences
10% Straight line
1.5
Tangible fixed assets
Tangible fixed assets are initially measured at cost, net of depreciation and any impairment losses.
Depreciation is recognised so as to write off the cost of assets less their residual values over their useful lives on the following bases:
Property Improvements
20% straight line
Fixtures & Fittings
20% reducing balance
Computer Equipment
25% straight line
Motor Vehicles
25% straight line
The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.
1.6
Impairment of fixed assets
At each reporting period end date, the company reviews the carrying amounts of its tangible and intangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.
Recoverable amount is the higher of fair value less costs to sell and value in use. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset for which the estimates of future cash flows have not been adjusted.
If the recoverable amount of an asset (or cash-generating unit) is estimated to be less than its carrying amount, the carrying amount of the asset (or cash-generating unit) is reduced to its recoverable amount. An impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the impairment loss is treated as a revaluation decrease.
Recognised impairment losses are reversed if, and only if, the reasons for the impairment loss have ceased to apply. Where an impairment loss subsequently reverses, the carrying amount of the asset (or cash-generating unit) is increased to the revised estimate of its recoverable amount, but so that the increased carrying amount does not exceed the carrying amount that would have been determined had no impairment loss been recognised for the asset (or cash-generating unit) in prior years. A reversal of an impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the reversal of the impairment loss is treated as a revaluation increase.
RENAISSANCE CARE (NO 1) LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 NOVEMBER 2025
1
Accounting policies
(Continued)
- 13 -
1.7
Cash and cash equivalents
Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.
1.8
Financial instruments
The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.
Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.
Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.
Basic financial assets
Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.
Other financial assets
Other financial assets, including investments in equity instruments which are not subsidiaries, associates or joint ventures, are initially measured at fair value, which is normally the transaction price. Such assets are subsequently carried at fair value and the changes in fair value are recognised in profit or loss, except that investments in equity instruments that are not publicly traded and whose fair values cannot be measured reliably are measured at cost less impairment.
Impairment of financial assets
Financial assets, other than those held at fair value through profit and loss, are assessed for indicators of impairment at each reporting end date.
Financial assets are impaired where there is objective evidence that, as a result of one or more events that occurred after the initial recognition of the financial asset, the estimated future cash flows have been affected. If an asset is impaired, the impairment loss is the difference between the carrying amount and the present value of the estimated cash flows discounted at the asset’s original effective interest rate. The impairment loss is recognised in profit or loss.
If there is a decrease in the impairment loss arising from an event occurring after the impairment was recognised, the impairment is reversed. The reversal is such that the current carrying amount does not exceed what the carrying amount would have been, had the impairment not previously been recognised. The impairment reversal is recognised in profit or loss.
Derecognition of financial assets
Financial assets are derecognised only when the contractual rights to the cash flows from the asset expire or are settled, or when the company transfers the financial asset and substantially all the risks and rewards of ownership to another entity, or if some significant risks and rewards of ownership are retained but control of the asset has transferred to another party that is able to sell the asset in its entirety to an unrelated third party.
RENAISSANCE CARE (NO 1) LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 NOVEMBER 2025
1
Accounting policies
(Continued)
- 14 -
Classification of financial liabilities
Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.
Basic financial liabilities
Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.
Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.
Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.
Other financial liabilities
Derivatives, including interest rate swaps and forward foreign exchange contracts, are not basic financial instruments. Derivatives are initially recognised at fair value on the date a derivative contract is entered into and are subsequently re-measured at their fair value. Changes in the fair value of derivatives are recognised in profit or loss in finance costs or finance income as appropriate, unless hedge accounting is applied and the hedge is a cash flow hedge.
Debt instruments that do not meet the conditions in FRS 102 paragraph 11.9 are subsequently measured at fair value through profit or loss. Debt instruments may be designated as being measured at fair value through profit or loss to eliminate or reduce an accounting mismatch or if the instruments are measured and their performance evaluated on a fair value basis in accordance with a documented risk management or investment strategy.
Derecognition of financial liabilities
Financial liabilities are derecognised when the company’s contractual obligations expire or are discharged or cancelled.
1.9
Equity instruments
Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.
1.10
Taxation
The tax expense represents the sum of the tax currently payable and deferred tax.
Current tax
The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.
RENAISSANCE CARE (NO 1) LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 NOVEMBER 2025
1
Accounting policies
(Continued)
- 15 -
Deferred tax
Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.
The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.
1.11
Employee benefits
The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.
The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.
1.12
Retirement benefits
Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.
1.13
Leases
As lessee
Leases are classified as finance leases whenever the terms of the lease transfer substantially all the risks and rewards of ownership to the lessees. All other leases are classified as operating leases.
Assets held under finance leases are recognised as assets at the lower of the assets fair value at the date of inception and the present value of the minimum lease payments. The related liability is included in the balance sheet as a finance lease obligation. Lease payments are treated as consisting of capital and interest elements. The interest is charged to profit or loss so as to produce a constant periodic rate of interest on the remaining balance of the liability.
Rentals payable under operating leases, including any lease incentives received, are charged to profit or loss on a straight line basis over the term of the relevant lease except where another more systematic basis is more representative of the time pattern in which economic benefits from the leases asset are consumed.
1.14
Foreign exchange
Transactions in currencies other than pounds sterling are recorded at the rates of exchange prevailing at the dates of the transactions. At each reporting end date, monetary assets and liabilities that are denominated in foreign currencies are retranslated at the rates prevailing on the reporting end date. Gains and losses arising on translation in the period are included in profit or loss.
RENAISSANCE CARE (NO 1) LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 NOVEMBER 2025
- 16 -
2
Auditor's remuneration
2025
2024
Fees payable to the company's auditor:
£
£
For audit services
Audit of the financial statements of the company
13,363
10,058
3
Employees
The average monthly number of persons (including directors) employed by the company during the year was:
2025
2024
Number
Number
Administrative staff
15
18
Management staff
24
24
Number of care staff
793
913
Total
832
955
Their aggregate remuneration comprised:
2025
2024
£
£
Wages and salaries
19,148,805
17,831,620
Pension costs
385,307
381,254
19,534,112
18,212,874
4
Directors' remuneration
2025
2024
£
£
Remuneration paid to directors
405,845
411,050
5
Taxation
2025
2024
£
£
Current tax
UK corporation tax on profits for the current period
203,377
213,167
Adjustments in respect of prior periods
7,234
(5,027)
Total current tax
210,611
208,140
RENAISSANCE CARE (NO 1) LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 NOVEMBER 2025
5
Taxation
2025
2024
£
£
(Continued)
- 17 -
Deferred tax
Origination and reversal of timing differences
99,677
3,065
Total tax charge
310,288
211,205
The actual charge for the year can be reconciled to the expected charge for the year based on the profit or loss and the standard rate of tax as follows:
2025
2024
£
£
Profit before taxation
1,881,623
1,853,646
Expected tax charge based on the standard rate of corporation tax in the UK of 25.00% (2024: 25.00%)
470,406
463,412
Tax effect of expenses that are not deductible in determining taxable profit
4,018
12,488
Adjustments in respect of prior years
7,234
(5,027)
Group relief
(315,992)
(136,341)
Permanent capital allowances in excess of depreciation
38,889
(126,392)
Deferred tax adjustments in respect of prior years
99,677
3,065
Loss on disposal of fixed assets
6,056
Taxation charge for the year
310,288
211,205
RENAISSANCE CARE (NO 1) LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 NOVEMBER 2025
- 18 -
6
Intangible fixed assets
Other
£
Cost
At 1 December 2024
36,236
Additions
1,686
Disposals
(8,340)
At 30 November 2025
29,582
Amortisation and impairment
At 1 December 2024
Amortisation charged for the year
3,993
At 30 November 2025
3,993
Carrying amount
At 30 November 2025
25,589
At 30 November 2024
36,236
7
Tangible fixed assets
Property Improvements
Fixtures & Fittings
Computer Equipment
Motor Vehicles
Total
£
£
£
£
£
Cost
At 1 December 2024
642,121
3,654,395
242,745
193,828
4,733,089
Additions
196,652
403,461
49,048
23,231
672,392
Business combinations
31,170
50,099
81,269
Disposals
(19,425)
(244,091)
(263,516)
At 30 November 2025
819,348
3,844,935
291,793
267,158
5,223,234
Depreciation and impairment
At 1 December 2024
383,358
1,726,012
126,115
152,470
2,387,955
Depreciation charged in the year
70,946
434,046
56,527
76,004
637,523
Eliminated in respect of disposals
(17,865)
(221,426)
(239,291)
At 30 November 2025
436,439
1,938,632
182,642
228,474
2,786,187
Carrying amount
At 30 November 2025
382,909
1,906,303
109,151
38,684
2,437,047
At 30 November 2024
258,763
1,928,383
116,630
41,358
2,345,134
Tangible fixed assets with a carrying amount of £2,437,047 (2024 - £2,345,134) have been pledged to secure borrowings of the company. The company is not allowed to pledge these assets as security for other borrowings or sell them to another entity.
RENAISSANCE CARE (NO 1) LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 NOVEMBER 2025
- 19 -
8
Debtors
2025
2024
Amounts falling due within one year:
£
£
Trade debtors
1,331,374
1,506,346
Amounts owed by group undertakings
11,015,139
8,791,004
Other debtors
652,497
772,380
12,999,010
11,069,730
9
Creditors: amounts falling due within one year
2025
2024
£
£
Trade creditors
1,566,654
1,407,398
Amounts owed to group undertakings
5,581,543
5,091,054
Corporation tax
101,688
100,406
Other taxation and social security
1,411,804
1,574,702
Other creditors
3,246,698
2,948,191
11,908,387
11,121,751
Landlords of leased properties hold standard securities over their respective properties and floating charges over the undertaking, property and assets of the individual legal entities whose business operated from their homes. No rental guarantees have been granted by Renaissance Care (UK) Limited, Renaissance Care (Scotland) Limited or Dow Investments PLC. Renaissance Care (Scotland) Limited has granted a guarantee to Impact Property 3 Limited.
10
Creditors: amounts falling due after more than one year
2025
2024
£
£
Other creditors
17,888
11
Finance lease obligations
2025
2024
Amounts due:
£
£
Within one year
4,505
After more than one year
17,888
-
22,393
RENAISSANCE CARE (NO 1) LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 NOVEMBER 2025
11
Finance lease obligations
(Continued)
- 20 -
2025
2024
Future minimum lease payments due under finance leases:
£
£
Within one year
4,505
In two to five years
17,888
22,393
Finance lease payments represent rentals payable by the company for certain items of plant and machinery. Leases include purchase options at the end of the lease period, and no restrictions are placed on the use of the assets. The average lease term is 4 years. All leases are on a fixed repayment basis and no arrangements have been entered into for contingent rental payments.
12
Provisions for liabilities
2025
2024
£
£
Deferred tax liabilities
469,352
369,675
13
Retirement benefit schemes
2025
2024
Defined contribution schemes
£
£
Charge to profit or loss in respect of defined contribution schemes
385,307
381,254
The company operates a defined contribution pension scheme for all qualifying employees. The assets of the scheme are held separately from those of the company in an independently administered fund.
14
Operating lease commitments
As lessee
At the reporting end date the company had outstanding commitments for future minimum lease payments under non-cancellable operating leases, as follows:
2025
2024
£
£
Total commitments
79,669,970
82,399,844
15
Related party transactions
The company has taken advantage of the exemption conferred by Financial Reporting Standard 102 Section 1A not to disclose inter-group transactions and balances on the grounds that 100% of the voting rights of the company are controlled within the group and that consolidated accounts are prepared by the ultimate holding company Dow Investments PLC and are publicly available at the address detailed below.
RENAISSANCE CARE (NO 1) LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 NOVEMBER 2025
- 21 -
16
Parent company
The immediate parent company is Renaissance Care (UK) Limited, a company incorporated in Scotland which held 100% of the ordinary share capital of the company throughout the current and previous financial period.
The directors consider the ultimate controlling party to be Dow Investments PLC, a company incorporated in Scotland, as a result of its controlling interest in Renaissance Care (Scotland) Limited. Dow Investments PLC is controlled by Mr R D Kilgour, director.
The accounts of Dow Investments PLC are available to the public via Companies House. The registered office of this company is Archibald Hope House, Station Road, Musselburgh, Scotland, EH21 7PQ. The company heads its largest group and smallest group in which the results of this company are included.
17
Cash generated from operations
2025
2024
£
£
Profit after taxation
1,571,335
1,642,441
Adjustments for:
Taxation charged
310,288
211,205
Finance costs
661
743
Investment income
(3,103)
(4,572)
Loss/(gain) on disposal of tangible fixed assets
24,225
(5,411)
Amortisation and impairment of intangible assets
3,993
Depreciation and impairment of tangible fixed assets
637,523
538,406
Movements in working capital:
Increase in debtors
(1,929,280)
(1,754,554)
Increase in creditors
789,859
1,343,195
Cash generated from operations
1,405,501
1,971,453
18
Analysis of changes in net funds
1 December 2024
Cash flows
30 November 2025
£
£
£
Cash at bank and in hand
1,622,834
429,214
2,052,048
Lease liabilities
(22,393)
22,393
-
1,600,441
451,607
2,052,048
2025-11-302024-12-01falsefalsefalseCCH SoftwareCCH Accounts Production 2026.100Mr R D KilgourMrs A NeilsonMrs L BarnettMr L M BainSC4020972024-12-012025-11-30SC402097bus:Director12024-12-012025-11-30SC402097bus:Director22024-12-012025-11-30SC402097bus:Director32024-12-012025-11-30SC402097bus:Director42024-12-012025-11-30SC402097bus:RegisteredOffice2024-12-012025-11-30SC402097bus:Agent12024-12-012025-11-30SC4020972025-11-30SC4020972023-12-012024-11-30SC402097core:RetainedEarningsAccumulatedLosses2023-12-012024-11-30SC402097core:RetainedEarningsAccumulatedLosses2024-12-012025-11-30SC4020972024-11-30SC402097core:IntangibleAssetsOtherThanGoodwill2025-11-30SC402097core:IntangibleAssetsOtherThanGoodwill2024-11-30SC402097core:LandBuildingscore:OwnedOrFreeholdAssets2025-11-30SC402097core:FurnitureFittings2025-11-30SC402097core:ComputerEquipment2025-11-30SC402097core:MotorVehicles2025-11-30SC402097core:LandBuildingscore:OwnedOrFreeholdAssets2024-11-30SC402097core:FurnitureFittings2024-11-30SC402097core:ComputerEquipment2024-11-30SC402097core:MotorVehicles2024-11-30SC402097core:CurrentFinancialInstrumentscore:WithinOneYear2025-11-30SC402097core:CurrentFinancialInstrumentscore:WithinOneYear2024-11-30SC402097core:Non-currentFinancialInstrumentscore:AfterOneYear2025-11-30SC402097core:Non-currentFinancialInstrumentscore:AfterOneYear2024-11-30SC402097core:CurrentFinancialInstruments2025-11-30SC402097core:CurrentFinancialInstruments2024-11-30SC402097core:ShareCapital2025-11-30SC402097core:ShareCapital2024-11-30SC402097core:RetainedEarningsAccumulatedLosses2025-11-30SC402097core:RetainedEarningsAccumulatedLosses2024-11-30SC402097core:ShareCapital2023-11-30SC402097core:RetainedEarningsAccumulatedLosses2023-11-30SC4020972024-11-30SC4020972023-11-30SC402097core:IntangibleAssetsOtherThanGoodwill2024-12-012025-11-30SC402097core:PatentsTrademarksLicencesConcessionsSimilar2024-12-012025-11-30SC402097core:LandBuildingscore:OwnedOrFreeholdAssets2024-12-012025-11-30SC402097core:FurnitureFittings2024-12-012025-11-30SC402097core:ComputerEquipment2024-12-012025-11-30SC402097core:MotorVehicles2024-12-012025-11-30SC402097core:UKTax2024-12-012025-11-30SC402097core:UKTax2023-12-012024-11-30SC40209712024-12-012025-11-30SC40209712023-12-012024-11-30SC402097core:IntangibleAssetsOtherThanGoodwill2024-11-30SC402097core:LandBuildingscore:OwnedOrFreeholdAssets2024-11-30SC402097core:FurnitureFittings2024-11-30SC402097core:ComputerEquipment2024-11-30SC402097core:MotorVehicles2024-11-30SC402097core:Non-currentFinancialInstruments2025-11-30SC402097core:Non-currentFinancialInstruments2024-11-30SC402097core:WithinOneYear2025-11-30SC402097core:WithinOneYear2024-11-30SC402097core:BetweenTwoFiveYears2025-11-30SC402097core:BetweenTwoFiveYears2024-11-30SC402097bus:PrivateLimitedCompanyLtd2024-12-012025-11-30SC402097bus:FRS1022024-12-012025-11-30SC402097bus:Audited2024-12-012025-11-30SC402097bus:FullAccounts2024-12-012025-11-30xbrli:purexbrli:sharesiso4217:GBP